Illinois General Assembly - Full Text of HB1282
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

Full Text of HB1282  103rd General Assembly

HB1282 103RD GENERAL ASSEMBLY

  
  

 


 
103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB1282

 

Introduced 1/31/2023, by Rep. Daniel Didech

 

SYNOPSIS AS INTRODUCED:
 
410 ILCS 620/17.3 new

    Amends the Illinois Food, Drug and Cosmetic Act. Provides that, beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains specified intentionally added ingredients. Provides an exception to the prohibition. Contains other provisions.


LRB103 05003 CPF 50015 b

 

 

A BILL FOR

 

HB1282LRB103 05003 CPF 50015 b

1    AN ACT concerning health.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Food, Drug and Cosmetic Act is
5amended by adding Section 17.3 as follows:
 
6    (410 ILCS 620/17.3 new)
7    Sec. 17.3. Cosmetic safety.
8    (a) It is the intent of the General Assembly to prohibit
9the presence of intentionally added ingredients in cosmetics,
10consistent with the European Union's prohibition on the
11presence of intentionally added ingredients in cosmetics.
12    (b) In this Section, "ingredient" means any component of a
13cosmetic product as that term is defined under 21 CFR 700.3.
14    (c) Beginning January 1, 2025, no person or entity shall
15manufacture, sell, deliver, hold, or offer for sale in
16commerce any cosmetic product that contains any of the
17following intentionally added ingredients:
18        (1) Dibutyl phthalate (CAS no. 84-74-2).
19        (2) Diethylhexyl phthalate (CAS no. 117-81-7).
20        (3) Formaldehyde (CAS no. 50-00-0).
21        (4) Paraformaldehyde (CAS no. 30525-89-4).
22        (5) Methylene glycol (CAS no. 463-57-0).
23        (6) Quaternium-15 (CAS no. 51229-78-8).

 

 

HB1282- 2 -LRB103 05003 CPF 50015 b

1        (7) Mercury (CAS no. 7439-97-6).
2        (8) Isobutylparaben (CAS no. 4247-02-3).
3        (9) Isopropylparaben (CAS no. 4191-73-5).
4        (10) m-Phenylenediamine and its salts (CAS no.
5    108-45-2).
6        (11) o-Phenylenediamine and its salts (CAS no.
7    95-54-5).
8        (12) The following per- and polyfluoroalkyl substances
9    (PFAS) and their salts:
10            (A) Perfluorooctane sulfonate (PFOS) or
11        heptadecafluorooctane-1-sulfonic acid (CAS no.
12        1763-23-1).
13            (B) Potassium perfluorooctanesulfonate or
14        potassium heptadecafluorooctane-1-sulfonate (CAS no.
15        2795-39-3).
16            (C) Diethanolamine perfluorooctane sulfonate (CAS
17        70225-14-8).
18            (D) Ammonium perfluorooctane sulfonate or ammonium
19        heptadecafluorooctanesulfonate (CAS 29081-56-9).
20            (E) Lithium perfluorooctane sulfonate or lithium
21        heptadecafluorooctanesulfonate (CAS 29457-72-5).
22            (F) Perfluorooctanoic acid (PFOA) (CAS no.
23        335-67-1).
24            (G) Ammonium pentadecafluorooctanoate (CAS no.
25        3825-26-1).
26            (H) Nonadecafluorodecanoic acid (CAS no.

 

 

HB1282- 3 -LRB103 05003 CPF 50015 b

1        355-76-2).
2            (I) Ammonium nonadecafluorodecanoate (CAS no.
3        3108-42-7).
4            (J) Sodium nonadecafluorodecanoate (CAS no.
5        3830-45-3).
6            (K) Perfluorononanoic acid (PFNA) (CAS no.
7        375-95-1).
8            (L) Sodium heptadecafluorononanoate (CAS no.
9        21049-39-8).
10            (M) Ammonium perfluorononanoate (CAS no.
11        4149-60-4).
12    (d) A cosmetic product is not in violation of this Section
13if:
14        (1) the cosmetic product is made through manufacturing
15    processes that are intended to comply with this Section;
16        (2) the cosmetic product contains a technically
17    unavoidable trace quantity of an ingredient listed in
18    subsection (c); and
19        (3) the trace quantity stems from impurities of
20    natural or synthetic ingredients, the manufacturing
21    process, storage, or migration from packaging.